SARS‐CoV ‐2 vaccine‐triggered conversion from systemic lupus erythematosus ( SLE ) to bullous SLE and dipeptidyl peptidase 4 inhibitors‐associated bullous pemphigoid

Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19

(2022) Ilona Nln et al.   Translational Research

Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study

(2022) Carlo Alberto Maronese et al.   Frontiers in Medicine

Subepidermal Autoimmune Blistering Dermatoses: Clinical Features and Diagnosis

(2021) Carmen M. Montagnon et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases

(2021) Devon E. McMahon et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination

(2021) Abdulla Watad et al.   Vaccines

Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination

(2021) Mary M. Tomayko et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Evaluation of Immune Response and Disease Status in SLE Patients Following SARS‐CoV‐2 Vaccination

(2021) Peter M. Izmirly et al.   Arthritis & Rheumatology

Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases

(2020) Aristo Vojdani et al.   CLINICAL IMMUNOLOGY

New insights into the immunopathogenesis of systemic lupus erythematosus

(2016) George C. Tsokos et al.   Nature Reviews Rheumatology

A pathogenic IFNα, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients

(2016) Patricia López et al.   Scientific Reports

Bullous Systemic Lupus Erythematosus: A Review and Update to Diagnosis and Treatment

(2014) James J. Contestable et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY